[New Czechoslovak cytostatic preparation Cytembena in the treatment of rheumatoid arthritis (author's transl)]. 1973

P Truhlár, and P Machácek, and O Smahel

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D003604 Czechoslovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000179 Acrylates Derivatives of acrylic acid (the structural formula CH2
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

P Truhlár, and P Machácek, and O Smahel
January 1975, Casopis lekaru ceskych,
P Truhlár, and P Machácek, and O Smahel
January 1980, Ceskoslovenska gynekologie,
P Truhlár, and P Machácek, and O Smahel
July 1981, Anales espanoles de pediatria,
P Truhlár, and P Machácek, and O Smahel
December 1980, Deutsche medizinische Wochenschrift (1946),
P Truhlár, and P Machácek, and O Smahel
November 1977, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
P Truhlár, and P Machácek, and O Smahel
August 1975, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca,
P Truhlár, and P Machácek, and O Smahel
February 1978, Ryumachi. [Rheumatism],
P Truhlár, and P Machácek, and O Smahel
February 1982, Ryumachi. [Rheumatism],
P Truhlár, and P Machácek, and O Smahel
December 1977, Deutsche medizinische Wochenschrift (1946),
P Truhlár, and P Machácek, and O Smahel
September 1981, Ryumachi. [Rheumatism],
Copied contents to your clipboard!